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Despite being more and more common, and having a high impact on the quality of
life of sufferers, tinnitus does not yet have a cure. This has been mostly the result
of limited knowledge of the biological mechanisms underlying this adverse pathology.
However, the last decade has witnessed tremendous progress in our understanding on the
pathophysiology of tinnitus. Animal models have demonstrated that tinnitus is a pathology
of neural plasticity, and has two main components: a molecular, peripheral component
related to the initiation phase of tinnitus; and a system-level, central component-related
to the long-term maintenance of tinnitus. Using the most recent experimental data
and the molecular/system dichotomy as a framework, we describe here the biological
basis of tinnitus. We then discuss these mechanisms from an evolutionary perspective,
highlighting similarities with memory. Finally, we consider how these discoveries can
translate into therapies, and we suggest operative strategies to design new and effective
combined therapeutic solutions using both pharmacological (local and systemic) and
behavioral tools (e.g., using tele-medicine and virtual reality settings).
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INTRODUCTION
Worsened in Western countries by the deleterious combination
of population aging and increased noise pollution, tinnitus—the
perception of sound in silence—is a major problem of public
health (Nicolas-Puel et al., 2002; Nondahl et al., 2007; Belli et al.,
2008; Muluk and Oguzturk, 2008). Unfortunately, and despite
the fact that tinnitus strongly alters the quality of life of sufferers
(Nicolas-Puel et al., 2002; Nondahl et al., 2007; Belli et al., 2008;
Muluk and Oguzturk, 2008), no effective therapeutic strategy
exists. Thus, tinnitus is the target of intense research by biomedi-
cal scientists investigating the physiology and the pathophysiology
of the auditory system. The understanding of the neurobiological
basis of tinnitus also bears major theoretical problems, which are
of interest to a broad range of neuroscientists (Eggermont and
Roberts, 2004; Guitton, 2006; Guitton and Dudai, 2007). Which
alterations of neural systems can lead to the development of a
stable phantom percept? Since tinnitus is actually an “off-line”
sound, can it be compared to memory, which allows the “off-line”
recall of past events? Are the neurobiological mechanisms under-
lying these two apparently distinct phenomena similar? In recent
years, tremendous progresses in our understanding of some of
the biological basis of this devastating pathology have been made
(Guitton et al., 2003; Eggermont and Roberts, 2004; Guitton and
Dudai, 2007).
In the last decade, animal research has clearly demonstrated
that tinnitus is a pathology of synaptic plasticity (Guitton et al.,
2003; Guitton and Dudai, 2007). However, the research done
using animal models has also pointed to dual aspects of the bio-
logical mechanisms underlying the ontogeny of tinnitus. Indeed,
if tinnitus originates into the cochlea, at the level of the synapse
between the auditory hair cells and the primary auditory neu-
rons, its perception and long-term maintenance involves com-
plex networks in the central nervous system, both in auditory
and in non-auditory (among them limbic) structures. Thus, the
biology of tinnitus comprises both molecular and system-level
components.
Considering the most recent experimental results, we will
describe some of the biological mechanisms underlying tinnitus,
specifically the phase of initiation and of long-term maintenance
of tinnitus, keeping in mind the dual molecular/system aspects of
this pathology of synaptic plasticity. We will then discuss these
aspects from an evolutionary perspective, and present, in light
of the most recent developments in tinnitus research, similarities
between tinnitus and memory, to suggest theoretical frameworks
to further tinnitus research. Finally, we will consider how a better
understanding of the molecular and system-level mechanisms of
tinnitus can translate into new, innovative, and effective targeted
therapeutic strategies, both pharmacological and behavioral.
MECHANISMS OF TINNITUS
CELLULAR LEVEL
The common goal of all the research performed on tinnitus is to
get closer to understanding the biological mechanisms of tinnitus,
in order to develop therapeutic solution to cure this pathology.
Toward that end, the lingering question for most researchers in
the field has been to identify the origin of tinnitus, i.e., both
the anatomical location of the dysfunction that leads to tinni-
tus, and the molecular mechanisms underlying this abnormal
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phenomenon (Eggermont and Roberts, 2004; Eggermont, 2006;
Guitton, 2006; Guitton and Dudai, 2007).
Heated debates arose in the field of tinnitus regarding the
anatomical origin of tinnitus, exacerbated by the fact that tinnitus
is not a single pathology, but rather a multiform symptom (see
Guitton, 2006 for review). Tinnitus can appear concomitantly
to hearing lost, to presbycusis, to drug intoxication, to neuri-
noma . . . . Thus, various origins could account for various forms
of tinnitus. However—and despite this heterogeneity—the final
result is the same (i.e., the transmission of an abnormal message
through the auditory pathways), suggesting that, at least for some
forms of tinnitus, a common biological basis could be identified.
Since in most cases tinnitus co-appears with problems of the
inner ear, clinical evidence has suggested a peripheral origin for
the majority of tinnitus (Loeb and Smith, 1967; Nicolas-Puel
et al., 2002; Guitton, 2006). The cochlea—the primary auditory
organ, i.e., the structure dedicated to the transduction of acoustic
signals into biological neural messages—represented a candidate
of interest for a “tinnitus generator.” However, in order to solve
this fascinating enigma, researchers were in need of appropri-
ate animal models. Two specific sub-types of animal models of
tinnitus contributed to major advances in the identification of
some of the molecular pathways involved in this genesis: first,
a particular form of drug-induced tinnitus—salicylate-induced
tinnitus—and second, noise-induced tinnitus. When applied at
high enough concentration, salicylate treatment is known to
induce tinnitus in 100% of cases, characterize as being high-
pitch, short-term. and reversible (Cazals, 2000; Guitton et al.,
2003; Puel and Guitton, 2007). Thus, salicylate-induced tinni-
tus represents an ideal, highly controlled, experimental model
(Guitton et al., 2003; Guitton and Dudai, 2007; Puel and Guitton,
2007). However, the clinical relevance of salicylate-induced tin-
nitus is rather low. In contrast, noise-induced tinnitus presents a
completely opposite profile. Noise overexposure produces long-
term, mostly irreversible, and clinically highly relevant tinnitus.
However, not all subjects (human or animal) exposed to high lev-
els of noise will develop tinnitus (Heffner and Harrington, 2002;
Guitton and Dudai, 2007).
These two opposite models of tinnitus were instrumental for
understanding the biological mechanisms underlying the initia-
tion phase of tinnitus. As an abnormal auditory perception, the
biological message which is perceived as tinnitus should origi-
nate somewhere in the early neural pathways. Thus, the synapse
between the sensory inner hair cells and the primary auditory
neuron and the primary auditory neurons themselves are interest-
ing candidates for the site of initiation of tinnitus. Animal models
helped us to decipher how salicylate treatment could lead to the
genesis of an abnormal neural signal. Indeed, salicylate is a potent
inhibitor of cyclooxygenase. The blockade of this enzyme triggers
an increase in the concentration of arachidonic acid in cell mem-
branes (Guitton and Puel, 2004). Some ion channel receptors, and
particularly the NMDA receptors of glutamate, are highly sensi-
tive to the lipid composition of cell membranes. Accumulation of
arachidonic acid thus mechanically “stretches” NMDA receptors,
increasing their opening probability (Miller et al., 1992; Casado
and Ascher, 1998). That is exactly what happens in the mam-
malian cochlea (Guitton et al., 2003; Guitton and Puel, 2004;
Ruel et al., 2008). Interestingly, in the cochlea, this mechanism
was demonstrated first in vivo using a unique combination of
pharmacological and behavioral techniques (Guitton et al., 2003,
2005; Guitton and Dudai, 2007), before being confirmed in vitro
(Peng et al., 2003; Ruel et al., 2008). In vivo studies demonstrated
that the local intracochlear application of NMDA antagonists was
able to abolish the perception of behaviorally assessed tinnitus
induced by the cyclooxygenase inhibitors salicylate and mefe-
namate (Guitton et al., 2003, 2005; Guitton and Dudai, 2007).
In vitro electrophysiological studies confirmed that salicylate was
able to specifically act on cochlear NMDA receptors both in cul-
tures of primary auditory neurons and in cochlear slices (Peng
et al., 2003; Ruel et al., 2008).
However, drug-induced tinnitus accounts for only a very
limited proportion of tinnitus in humans (Nicolas-Puel et al.,
2002). Clinically, the main direct cause of tinnitus is overexpo-
sure to noise (Loeb and Smith, 1967; Guitton, 2006; Nicolas-Puel
et al., 2002). Noise overexposure can produce various alter-
ations of auditory function, ranging from very subtle changes
of cochlear micro-mechanics to major hearing loss and deafness
(Avan et al., 2000; Kossowski et al., 2001; Le Prell et al., 2006;
Ohlemiller, 2008). Overexposure to noise has also been demon-
strated to trigger tinnitus in animals (Heffner and Harrington,
2002; Heffner and Koay, 2005; Guitton and Dudai, 2007). Data
obtained using combined pharmacological and behavioral strate-
gies in rats demonstrated that it was possible to extend the
mechanism unveiled with salicylate-induced tinnitus to long-
term noise-induced tinnitus (Guitton and Dudai, 2007). Indeed,
local intracochlear application of NMDA receptor antagonists
was able to prevent the occurrence of noise-induced tinnitus in
100% of cases, when applied around the time of induction of
tinnitus by noise overexposure (Guitton and Dudai, 2007). This
blockade was specific to NMDA receptors, as AMPA receptor
antagonists, and 5-HT receptors antagonists did not prevent the
onset of tinnitus (Guitton and Dudai, 2007). Furthermore, in
the case of noise-induced tinnitus, the sensitivity of this process
to NMDA receptor blockade remains for several days after the
initial noise overexposure (Guitton and Dudai, 2007). Thus, the
initial phase of both salicylate-induced and noise-induced tinni-
tus is dependant on NMDA receptor activity in primary auditory
neurons.
SYSTEM LEVEL
The evidence that tinnitus originates from single synapses in the
periphery of the auditory system does not, however, contradict
the involvement of central parts of the auditory system. Sensory
messages originate from the peripheral organs, but perception
itself is a phenomenon subserved by system activity, i.e., sub-
cortical and cortical neural networks. Tinnitus is not different
from other sensory phenomena.
After a phase of initiation, corresponding to the ontogeny
of tinnitus in the cochlea, tinnitus undergoes a phase of long-
term maintenance. Likely, the biological mechanisms sustaining
tinnitus during this second phase are hybrid: localized mech-
anisms within the cochlea, and distributed mechanisms along-
side the central—auditory and non-auditory—neural networks
(Eggermont and Roberts, 2004; Guitton, 2006).
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Auditory neural networks are central in the perception of
tinnitus, as well as in its long-term aspects. Central auditory path-
ways are known to be the target of intense plasticity (Bledsoe
et al., 2003). Occurrence of tinnitus triggers various forms of
alteration in central auditory structures. In parallel to the research
done on the molecular basis of tinnitus, intense research has been
performed to unveil the neural networks affected by the pres-
ence of tinnitus (Eggermont and Roberts, 2004; Eggermont, 2006;
Noreña et al., 2006).
An important phenomenon confirms the system-level involve-
ment in the pathophysiology of tinnitus. Indeed, while the vast
majority of tinnitus appears concomitantly to hearing loss, the
onset of tinnitus often correlates with stressful events rather than
with the onset of hearing loss (Guitton, 2006; Nicolas-Puel et al.,
2002). This apparent paradox is easy to explain when consider-
ing that, under normal conditions, the human brain is able to
“filter” aberrant neuronal activities propagated along auditory
structures—which would be perceived as tinnitus—from the flow
of pertinent sensory information. Considering the clinical real-
ity of tinnitus, it is easy to further the analogy between tinnitus
andmemory, by considering that anxiety and other negative emo-
tions act as reinforcing factors. Initially, tinnitus exists below the
threshold of perception, and is thus “masked” and unperceived.
Following a stressful event, a transient increase of anxiety lev-
els triggers a lowering of the threshold of perception. Tinnitus
is consequently “unmasked,” and begins to be actually perceived.
Finally, the perception of tinnitus triggers more anxiety, which
in return reinforces tinnitus (Figure 1). Data obtained in ani-
mal models showing that anxiety induced by a serotonergic agent
was able to exacerbate the perception of tinnitus support this
system-based mechanism (Guitton et al., 2005).
The relationship between tinnitus and anxiety strongly sug-
gests that, among the non-auditory pathways, the limbic system is
involved in the long-term maintenance of tinnitus (Guitton et al.,
2005; Guitton, 2006). For instance, salicylate treatment known
FIGURE 1 | Modulation of the perceived intensity of tinnitus by
anxiety. Phase 1: Tinnitus exists below the threshold of perception, in an
unperceived state. Phase 2: The occurrence of a stressful event lowers the
threshold of perception. Tinnitus thus gets unmasked, and begins to be
perceived. Phase 3: Tinnitus triggers anxiety, which in turn reinforce the
perception of tinnitus, leading to a “vicious circle.”
to induce tinnitus elicits plastic changes in limbic structures—
notably in the amygdala—in addition to central auditory struc-
tures (Wallhäusser-Franke et al., 2003; Mahlke and Wallhäusser-
Franke, 2004). Furthermore, the limbic system—the “emotional
brain”—can be strongly activated by perceptual cues, leading
to powerful conditioning, such as auditory fear conditioning
(Apergis-Schoute et al., 2005; Ben Mamou et al., 2006). Thus, the
neuronal circuitry underlying the link between auditory memo-
ries and emotional systems exists within the brain, providing a
biological substrate for a limbic modulation of off-line auditory
information.
One of the effects of this mobilization of central systems,
whether related or not to the primary auditory pathways, is the
impact of tinnitus on social behaviors. Indeed, tinnitus is often
accompanied by significant alterations of high-level cognitive
functions, particularly inter-individual and social interactions.
Such alterations clearly add to the burden of tinnitus on the
patients and their families, and strongly impair the professional
activities of the sufferers. Similar effects have been demonstrated
in animals, using standardized assessment of social behavior
(Guitton et al., 2008; Guitton, 2009). When perceiving tinni-
tus, animals exhibit striking alterations of their social behavior:
tinnitus-perceiving animals actively seek inter-individual contact,
but once the social interactions are initiated, they are unable to
sustain them (Guitton, 2009).
EVOLUTIONARY PERSPECTIVES: SIMILARITIES WITH
MEMORY
CELLULAR LEVEL
Since evolutionary processes favor the selection of the most
efficient phenotypes, how could the conditions for a synaptic
pathology such as tinnitus have emerged in the highly evolved
mammals’ auditory system? The biological mechanisms of tinni-
tus, as described earlier, calls for a direct comparison with mem-
ory, both at the molecular and at the system-levels. Memory—the
retention of information over time—is considered to be sup-
ported at the biological level by the plasticity of neurons and
neuronal structures.
Although normal neurotransmission between the inner hair
cells and the primary auditory neurons involves AMPA recep-
tors of glutamate and not NMDA receptors, NMDA receptors
still exist in the mammalian cochlea, and are activated under cer-
tain conditions, e.g., during the regrowth process after excitotoxic
injury (d’Aldin et al., 1997). Thus, auditory neurons still have the
potential for NMDA receptor dependant structural plasticity.
With its nature of NMDA receptor dependantmechanism, and
its temporal pattern, the slow synaptic plasticity associated with
the initiation of tinnitus shares striking similarities with what is
observed in memory, especially during the consolidation period
(Shimizu et al., 2000; Dudai, 2004; Ben Mamou et al., 2006;
Takehara-Nishiuchi et al., 2006). Both phenomena are dependant
on NMDA receptors containing the 2B subunit (NR2B). Indeed,
the involvement of this particular subunit is known to be critical
for memory formation (Nicoll and Malenka, 1995; Rosenblum
et al., 1996; Sotres-Bayon et al., 2007). Similarly, studies in ani-
mal model have demonstrated that a NR2B-targetted blockade
of cochlear NMDA receptor activity using the pharmacological
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agent ifenprodil—a NR2B antagonist—was sufficient to abol-
ish the perception of long-term noise-induced tinnitus in rats
(Guitton and Dudai, 2007). Another cue lies in the fact that sali-
cylate treatment known to induce tinnitus triggers modifications
of the expression of the transcription factor c-fos (Wallhäusser-
Franke et al., 2003; Mahlke andWallhäusser-Franke, 2004), which
is considered to be one of the markers of a memory-related form
of neural plasticity (Reijmers et al., 2007). In addition, salicylate
treatment induces changes in the expression of the transcription
factor CaRF1, involved in the regulation of BDNF (Singer et al.,
2008). Accordingly to molecular similarities between tinnitus
and memory (Guitton and Dudai, 2007), this consolidation-like
period should correspond to a phase in which tinnitus is still
labile, i.e., a period during which tinnitus could be erased by
pharmacological agents, as it has been demonstrated for non-
consolidated memory in other systems (Berman and Dudai,
2001). Indeed, during this period, tinnitus can be abolished by
cochlear application of NMDA antagonists (Guitton and Dudai,
2007), akin to what is observed in memory (Berman and Dudai,
2001).
Primary auditory neurons seem to share with cortical neu-
rons the same NMDA-dependant plasticity (Guitton and Dudai,
2007). Whereas in cortical neurons this property leads to the
formation of memory, in the periphery, it can lead to the initi-
ation of tinnitus (memory of a sound . . . ). Finally, memories are
dynamic and may enter anew into a labile state when retrieved,
in a process called reconsolidation (Dudai, 2006). Tinnitus could
actually undergo the same fate, or be in a state comparable to
“constant-reconsolidation.” Given the fact that consolidated audi-
tory fear memories have been shown to be dependant on NMDA
receptors activity (Ben Mamou et al., 2006), this last comparison
between tinnitus and memory opens important avenues in the
development of new therapeutic strategies to cure tinnitus, as well
as in our understanding of some of the biological mechanisms
underlying memory.
SYSTEM LEVEL
If the first stage of tinnitus could be qualified as a consolidation-
like process, what is the fate of tinnitus once this critical period
is over? This question of long-term maintenance of tinnitus is
critical for the understanding of this pathology, and for the devel-
opment of therapeutic strategies. A first possibility would be
that tinnitus “stays” in the periphery, but under the dependence
of other molecular pathways. A second hypothesis, which bears
fascinating conceptual avenues, is that over time tinnitus pro-
gressively recruits several anatomical structures (Figure 2)—the
peripheral auditory system, the central auditory system, the lim-
bic system, and higher-order brain structures (Eggermont and
Roberts, 2004; Eggermont, 2006; Guitton, 2006; Guitton and
Dudai, 2007). This distribution of the tinnitus engram from
one location to multiple locations strongly echoes the process
of system-level consolidation which appears in memory (Dudai,
2004, 2006). From an initial location—the cochlea for tinnitus,
and the medio-temporal lobe for different forms of memory
(Dudai, 2004)—the engram moves forward to complex net-
works of structures within the brain (Dudai, 2004). This second
hypothesis would thus explain how tinnitus with a peripheral
FIGURE 2 | Tinnitus and memory. Analogies between the consolidation
process occurring in memory and the translocation of the engram from the
medio-temporal lobe to complex cortical networks; and the putative
consolidation-like process which may lead to the translocation of tinnitus
from the cochlea to complex neuronal networks.
origin may undergo centralization (Figure 2). The significant
plasticity observed along the auditory structures after acoustic
trauma—evidenced both at the molecular (Milbrandt et al., 2000;
Wallhäusser-Franke et al., 2003; Mahlke and Wallhäusser-Franke,
2004) and system-levels through electrophysiological recordings
(Willott and Lu, 1982; Kimura and Eggermont, 1999; Kaltenbach
et al., 2004; Eggermont, 2006; Noreña et al., 2006)—may partly
account for the translocation of the engram corresponding to
tinnitus.
This comparison between the neuronal substrates of tinnitus
and those of memory could also be extended with another “off-
line” percept: chronic pain. In this case, the two phenomena also
share striking similarities at the molecular level, and a parallel
fate at the system-level. The early comparison between tinnitus
and “phantom limb” sensation, though not completely appro-
priate as tinnitus is not defined by the perception of a sound in
the context of total hearing loss, may still contain interesting ele-
ments for neuroscientists to explore. Recent data suggested that it
is possible to reverse some of the functional brain abnormal activ-
ity responsible for the perception of tinnitus in animals by using
brief electrical stimulations of the neural circuitry (Engineer
et al., 2011). Of course, direct translation of these experiments
in humans could be problematic, as “erasing” neural activity in
auditory structures could have deleterious impact on functions
such as language. Furthermore, the specificity of such approach
could be questioned. However, such results strongly reinforce the
notion of system involvement in the physiopathology of tinnitus.
THERAPEUTIC IMPLICATIONS
CELLULAR LEVEL
Identification of defined molecular pathways, in a specific cellu-
lar type and in a constrained anatomical location, allows for the
development of targeted pharmacological strategies. The devel-
opment of finely targeted therapeutic strategies is one of the key
trends of modern research in pharmacology. There are numer-
ous advantages of targeted strategies, including the decrease in the
drug concentration required to obtain a therapeutic result and the
diminution of unwanted side effects. However, the in situ real life
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application of such strategies is often bound by multiple practical
problems. Indeed, even drugs specifically designed to act on a par-
ticular receptor often have a reverse side. For instance, in highly
modulated biological systems, blocking one single sub-type of a
receptor may not be enough to block the biological function, as
compensatory mechanisms may take place. In addition, even the
most particular sub-type of a receptor may exist in different bio-
logical networks within an organism. Furthermore, despite the
targeting of a particular receptor, the limited expression of this
receptor may require the use of large concentrations of pharmaco-
logical agents, thus loosing part of the advantage of using targeted
strategies.
Such difficulties, however, seem to be less marked in the case
of tinnitus. Indeed, the cochlea offers all the characteristics of an
appealing target for organ-directed pharmacological approaches.
Due to its morphological characteristics, the cochlea is a natu-
ral chamber of perfusion. The sensory hair cells are surrounded
by liquids which are easily reachable through the round win-
dowmembrane via a trans-tympanic approach. Furthermore, the
contacts between the cochlear fluids and the cephalo-spinal fluid
are extremely limited, allowing the use of pharmacological agents
without risking the contamination of other neuronal structures.
As mentioned above, both salicylate-induced and noise-
induced tinnitus can be blocked in animals by local (cochlear)
application of NMDA antagonists (Guitton et al., 2003; Guitton
and Dudai, 2007). Local application allows the use of very small
doses of pharmacological agent, without major side effects in the
brain. The time window of sensitivity to NMDA antagonists is
several days after the trauma itself, which provides a long enough
time to act to cure tinnitus. However, local organ-targeted molec-
ular pharmacology approaches could still be used after these
first several days following the insult. Indeed, as NMDA recep-
tors seem to be common molecular integrators at the first stages
of tinnitus, other molecular pathways could be involved in the
later plastic changes underlying tinnitus. The molecular pathways
critically involved in pathophysiological mechanisms of auditory
structures represent appealing candidates for pharmacological
targets to cure long-term tinnitus. Among them, cytoskeletal
plasticity, with proteins such as Microtubule-associated Proteins
(MAPs) or activity-dependent cytoskeletal protein (Arg3.1, also
known as Arc) represents an interesting molecular pathway to
investigate (Ladrech et al., 2004; Panford-Walsh et al., 2008).
MAP has been reported to play a key-role in several patho-
physiological conditions in the cochlea, ranging from synap-
tic reorganization following noise overexposure in the cochlea
(Ladrech et al., 2004), to reaction to aminoglycoside toxicity
(Ladrech and Lenoir, 2002). Expression of several MAP iso-
forms (in particular the MAP2c isorform, known for its role
during the development of neurons) appears to be tightly regu-
lated during the repair processes that occur in primary auditory
neurons after excitotoxic injury in the cochlea, as well as after
cochlear intoxication by amikacin, one of the well-known oto-
toxic drug (Ladrech and Lenoir, 2002; Ladrech et al., 2004). In
this last case, the MAP pathway has been suggested to play a
key role in the survival of the remaining damaged sensory cells
(Ladrech and Lenoir, 2002). Results obtained on animal models
of salicylate-induced tinnitus demonstrated change of Arg3.1 and
BDNF during salicylate treatment in auditory structures, rein-
forcing the interest of cytoskeleton proteins as potential targets
of research for tinnitus (Panford-Walsh et al., 2008; Singer et al.,
2008). An alternative way to look at this problem of dysfunc-
tion of cochlear plasticity in tinnitus is to modulate the GABA-
dependant inhibition in the cochlea. Recent works demonstrated
that intra-cochlear application of midazolam [a GABA(A) recep-
tor modulator] resulted in the reversion of salicylate-induced
perception in animals (Panford-Walsh et al., 2008).
Finally, similar molecular approaches that aim at other struc-
tures of the auditory pathways could be developed. The inferior
colliculus, which has the advantages of being a relatively early
subcortical structure of the auditory pathways, and of being the
seat of significant levels of plasticity, represents a very interesting
target for pharmacologically-based therapies (Suga et al., 2000;
Bledsoe et al., 2003; Guitton, 2006). Thus, molecular targeting to
cure tinnitus could aim not only the periphery, but also at the
central auditory structures.
SYSTEM LEVEL
As stated above, discoveries made—and to come—of the molec-
ular pathways involved in the generation and maintenance of
tinnitus will lead to important therapeutic applications. However,
understanding and recognizing the system-level aspect of tinnitus
also bears promise for the development of possible therapeutic
strategies to cure tinnitus. It particularly allows for the optimiza-
tion of the design of advanced therapeutic strategies (Figure 3).
Although non-pharmacological strategies cannot abolish the
perception of tinnitus, system-based strategies have been proven
to have some effectiveness in helping sufferers to relieve some
of the symptoms of tinnitus. In other words, some system-based
strategies (masking, behavioral therapies) can help the sufferers to
FIGURE 3 | Conceptual framework to design therapeutic strategies to
cure tinnitus.
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learn to “live with tinnitus.” In the context of a pathology which
cannot yet be cured, such interventions should not be neglected.
The system-level characteristics of tinnitus provide the biologi-
cal mechanisms to explain how such complementary therapeutic
strategies operate.
Understanding of the system dynamics in tinnitus pathophysi-
ology, particularly the limbic component of tinnitus maintenance,
allows for thedevelopmentofmore complex combinedpharmaco-
logical strategies, as suggested earlier (Guitton et al., 2005;Guitton,
2006, 2009). Indeed, one of the most promising ways to cure tin-
nitus is the development of “hybrid” approaches, combining one
specific pharmacological agent aimed at the causal mechanisms
of tinnitus and acting on the abnormal neurotransmission in the
cochlea with a second less specific pharmacological agent aimed
at the symptoms, and regulating the abnormal neuromodula-
tion in centralized neural networks (Figure 3). For instance, an
NMDA antagonist locally applied in the cochlea could be used in
combination with a drug acting on anxiety levels (Guitton, 2006).
In this same line of idea, results obtained in animal suggested
that injection of an anxiolytic with action on potassium chan-
nels were able to suppress the perception of salicylate-induced
tinnitus (Lobarinas et al., 2011). Such molecule, which regu-
lates both neural activity and anxiety levels, could indeed be
an interesting candidate for innovative therapeutic strategies.
Understanding the system dynamics can also lead to other
non-pharmacological therapeutic strategies. Indeed, the involve-
ment of system dynamics in the maintenance of tinnitus is also
what sustains the relative effectiveness of behavioral strategies. In
this perspective, the utilization of tele-medicine and virtual real-
ity settings is likely to represent the future of tinnitus-oriented
behavioral therapies. Virtual settings, in which multimodality
prevails (Guitton, 2010; Lortie and Guitton, 2011), offer indeed
new possibilities for behavior-based therapies. The utilization
of virtual settings is clearly a way to optimize behavioral ther-
apies. Based on sensory process, tinnitus could be a potential
target for behavioral therapeutical strategies based on the use of
virtual tools.
CONCLUSION
The last decade has witnessed tremendous advances in our under-
standing of the biological basis of tinnitus. Currently, one of the
main challenges in tinnitus research is not necessarily to explore
further the biology of tinnitus, but rather to translate these fun-
damental discoveries into clinical applications. If we succeed in
doing so, all—researchers, clinicians, and more importantly the
patients—will benefit. Biomedical researchers would see their dis-
coveries applied, the feedback given would help to improve their
animal models; the clinicians would finally be able to propose
effective therapies to the patients; and the patients would finally
have a cure. The present review described some promising ways
to treat tinnitus. However, the fact that most evidence are com-
ing from behavioral and anatomical studies rather than clear
report of specific synaptic modifications in tinnitus strongly sug-
gest that more work on the synaptic physiology of this pathology
is needed.
Given the complexity and the heterogeneity of tinnitus, mono-
factorial strategies are likely to fail. Rather, a combination of
all the possible therapeutic weapons should ideally help us fight
this pathology. From a theoretical point of view, tinnitus, as a
pathology of synaptic plasticity involving both molecular path-
ways central for neuronal adaptation, and neuronal networks
involved in higher cognitive functions, could represent a powerful
model to further our understanding of the remarkable capacity of
the brain to adapt to environmental changes and to compute new
stimuli.
In conclusion, only a combined understanding of the molec-
ular and of the system-level dimensions of tinnitus will lead to
the emergence of innovative and effective therapeutic solutions to
help to cure this pathology and provide relief to the sufferers.
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